Groundbreaking Advances in Vascular and Venous Research Share Stage

Innovative Discoveries in Vascular Health to Be Unveiled

Leading physicians and researchers are thrilled to announce the presentation of results from 21 significant clinical trials at the upcoming annual VIVA and The VEINS conferences. These groundbreaking discoveries will take center stage from a Sunday to a Tuesday at the renowned Wynn Las Vegas.

Championing Knowledge in Vascular Medicine

VIVA (Vascular InterVentional Advances) stands as a pivotal educational symposium that emphasizes the numerous innovations in the field and fosters multidisciplinary learning. The 2024 conference marks VIVA's impressive 22nd anniversary and continues to be an essential gathering for specialists in peripheral vascular diseases.

Focusing on Venous Disorders

The VEINS (Venous Endovascular INterventional Strategies) symposium aims to provide a comprehensive view on the diagnosis, intervention, and management practices pertaining to venous disorders. This symposium plays a critical role in bringing together experts and specialists from various healthcare backgrounds.

Broad Spectrum of Specialists Gathered

The joint conferences attract an audience comprised of interventional cardiologists, vascular surgeons, interventional radiologists, and endovascular medicine specialists. An international, multidisciplinary faculty will contribute to a vibrant learning atmosphere that includes dynamic presentations, hands-on workshops, and intense discussions regarding the latest advancements in vascular care.

Clinical Trials Setting New Standards

Among the highlighted clinical trials, several impactful presentations include:

• The VEINS: Results from a pilot ENGULF trial showcasing clot burden reduction via a novel thrombectomy device.
• VIVA: Evaluating outcomes from the LIFE-BTK trial, focusing on innovative drug-eluting resorbable scaffolds intended for treating infrapopliteal lesions.
• Cutting-edge results from the PROMISE II trial addressing transcatheter arterialization of deep veins.
• Findings from studies comparing a new lithotripsy system against traditional methods within both above-the-knee and below-the-knee settings.

Each of these presentations aims to raise awareness about current issues and advances within the vascular field, showcasing the dedication to enhancing patient outcomes.

About the VIVA Foundation

The VIVA Foundation is a non-profit organization entirely committed to advancing the field of vascular medicine through systematic education and pioneering research efforts. The foundation plays a key role in facilitating high-quality educational events that embody a spirit of collaboration, pooling collective talents to elevate awareness and identify innovative treatments for vascular diseases globally.

Frequently Asked Questions

What is the VIVA and The VEINS conference about?

The conferences focus on the latest innovations and research in vascular and venous medicine, featuring presentations from experts in the field.

Who will be presenting the clinical trial results?

Leading surgeons and researchers in the vascular field will present their findings, contributing to advancements in patient care.

How will these findings impact patient care?

The results from these trials could influence treatment protocols and improve outcomes for patients with vascular and venous disorders.

What is the significance of VIVA’s 22nd anniversary?

It highlights the conference's long-standing commitment to education in vascular health and the continued evolution of treatment methods over two decades.

How can one learn more about the VIVA Foundation?

The VIVA Foundation offers comprehensive information on its mission and upcoming events at their official website.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.